About the Study This study is assessing whether a new targeted therapy (olomorasib) in combination with standard of care anti-cancer drugs (including immunotherapy and chemotherapy) is more effective than just …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
About the Study The main purpose of this study is to test a potential new treatment for early breast cancer. The study will measure how well a new hormone therapy …
CONDITION: Cancer
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
About the Maxpire IPF Study The Maxpire IPF Study is a clinical research study looking at a new investigational treatment for people living with Idiopathic Pulmonary Fibrosis (IPF). IPF is …
CONDITION: Respiratory
GENDER: All
AGE GROUP: 40 and above
TRIAL STATUS: Active, not recruiting
About the Study This study is evaluating a potential new oral treatment for adults with panic disorder, a mental health condition marked by sudden and repeated episodes of intense fear, …
CONDITION: Mental Health
GENDER: All
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
The study is designed as a clinical feasibility, to investigate the positive and negative percent agreement (PPA and NPA) of the BinaxNOW™ COVID-19/Flu A&B Combo against a highly sensitive PCR …
CONDITION: Infection
GENDER: Both males and females
AGE GROUP: 2 and above
TRIAL STATUS: Completed
This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19. It will also learn about the safety of …
CONDITION: Infection
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up complete
The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves’ Disease and to explore its effect on disease-specific biomarkers.
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers with gout to join a clinical study of a potential new treatment for gout flares. You may be eligible to join this trial if you: have …
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
Getting older affects every part of our health. As we age, our bodies gradually work less efficiently, making us more tired, less able to bounce back from illness or injury, …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 19 to 80 years
TRIAL STATUS: Closed: follow-up continuing
Do you have moderate to severe knee pain from osteoarthritis? You may be eligible to join a clinical study of a potential new treatment. Why this trial matters Osteoarthritis can …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Novatrials is enrolling volunteers with cardiovascular disease, and are living with obesity, in a clinical study of a potential new treatment that may help improve heart health outcomes. You may …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 45 to 85 years
TRIAL STATUS: Recruiting
If you suffer from recurring panic attacks and would like to help in the development of treatments, Novatrials is now running a clinical trial of a potential new treatment aimed …
CONDITION: Mental Health
GENDER:
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Do you have moderate to severe knee pain from osteoarthritis? You may be eligible to join a clinical study of a potential new treatment. Why this trial matters Osteoarthritis can …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Closed: follow-up continuing
Novatrials is now running a clinical trial of a potential treatment aimed at alleviating the symptoms of PN. If you are currently diagnosed with PN, would like to help in …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
Novatrials is now running a clinical study of a potential new treatment aimed at alleviating the symptoms of hyperuricemia. If you suffer with hyperuricemia or high serum uric acid, you …
CONDITION: Blood
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Closed: follow-up continuing
Novatrials is seeking volunteers who are overweight to join a clinical study of a potential new weight loss treatment. Under expert medical supervision, participants will explore an innovative new treatment …
CONDITION: Diet and Nutrition
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers with vitiligo to join a clinical trial of a potential new treatment. If you are over 18 years of age, either male or female and have …
CONDITION: Inflammatory and Immune System
GENDER:
AGE GROUP: 18 to 75 years
TRIAL STATUS: Closed: follow-up continuing
Novatrials are seeking volunteers with known heart conditions to join a clinical trial of a potential new treatment. If you are at least 18 years of age, either male or …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers with early symptoms of COVID-19 to join a clinical study of a potential new treatment. This treatment may help improve symptoms, and/or shorten the duration of …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Closed: follow-up complete
Chronic urticaria is a type of hives lasting six weeks or more without a known cause. Symptoms include red, itchy, raised welts on the skin that can range from small …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Closed: follow-up continuing
Participating in a clinical trial is about helping others. You will be helping in the development of new medications which will help improve or even save the lives of people …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
If you are at least 18 years of age, either male or female and: * currently have at least 20% scalp hair loss * you are able to attend appointments …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
In Australia, 2,000 people a day are treated for skin cancer and 2 in 3 Australians will be diagnosed with skin cancer by the age of 70. Your participation supports research designed …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
FB102-701: A Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Severe to Very Severe Alopecia Areata
CONDITION: Skin
GENDER: All
AGE GROUP: 18 to 75 years
TRIAL STATUS: Not yet recruiting
A Phase 2, Randomized, Open-label, Active- and Vehicle-controlled Comparator Study to Assess the Safety, Tolerability, and Efficacy of 2.4% Terbinafine Hydrochloride Topical Solution in Patients with Mild to Moderate Onychomycosis …
CONDITION: Skin
GENDER:
AGE GROUP: 18 to 70 years
TRIAL STATUS: Withdrawn
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa
CONDITION: Skin
GENDER: All
AGE GROUP: 18 to 75 years
TRIAL STATUS: Active, not recruiting
A Phase 3 Randomized, Active-Controlled, Open-Label Study to Evaluate a Switch to an Oral Weekly Islatravir/ Lenacapavir Regimen in People with HIV-1 Who are Virologically Suppressed on Standard of Care
CONDITION: Other
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
A Phase 3, Randomized, Active-controlled, Double-blind Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir (B/F/TAF)
CONDITION: Other
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
A Phase 3, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety and Immunogenicity of a SARS‑CoV‑2 rS Nanoparticle and Trivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine with Matrix-M™ Adjuvant and a …
CONDITION: Other
GENDER: All
AGE GROUP: 60 and above
TRIAL STATUS: Active, not recruiting